{
    "organizations": [],
    "uuid": "982a29128687ecdde1fdb5b956464fada4cff872",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-us-fda-requests-labeling-and-packa/brief-u-s-fda-requests-labeling-and-packaging-changes-for-otc-loperamide-idUSFWN1PP190",
    "ord_in_thread": 0,
    "title": "BRIEF-U.S. FDA Requests Labeling And Packaging Changes For OTC Loperamide",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 30 (Reuters) - U.S. Food and Drug Administration Commissioner Scott Gottlieb:\n* STATEMENT FROM FDA COMMISSIONER SCOTT GOTTLIEB - FDA IS REQUESTING THAT SPONSORS OF OTC LOPERAMIDE CHANGE THE WAY THEY LABEL AND PACKAGE THESE DRUGS\n* FDAâ€˜S GOTTLIEB - REQUESTING OTC MANUFACTURERS THAT PACKAGES CONTAIN LIMITED AMOUNT OF LOPERAMIDE APPROPRIATE FOR USE FOR SHORT-TERM DIARRHEA ACCORDING TO PRODUCT LABEL Source text for Eikon:\n ",
    "published": "2018-01-30T23:48:00.000+02:00",
    "crawled": "2018-01-31T16:22:02.005+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "food",
        "drug",
        "administration",
        "commissioner",
        "scott",
        "gottlieb",
        "statement",
        "fda",
        "commissioner",
        "scott",
        "gottlieb",
        "fda",
        "requesting",
        "sponsor",
        "otc",
        "loperamide",
        "change",
        "way",
        "label",
        "package",
        "drug",
        "fda",
        "gottlieb",
        "requesting",
        "otc",
        "manufacturer",
        "package",
        "contain",
        "limited",
        "amount",
        "loperamide",
        "appropriate",
        "use",
        "diarrhea",
        "according",
        "product",
        "label",
        "source",
        "text",
        "eikon"
    ]
}